Atlas Trials

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

Clinical trial NCT02516423 · TERMINATED

Trial details

NCT number
NCT02516423
Sponsor
Alliance for Clinical Trials in Oncology
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Solitary Osseous Plasmacytoma
Start date
2016-11-29
Primary completion
2024-09-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.